The loss of neurofibromin function leads to dysregulated cell growth, predisposing individuals to neurofibromas, plexiform neurofibromas, optic pathway gliomas, and malignant peripheral nerve sheath tumors [1]. The gene discussed is NF1; the disease is malignant peripheral nerve sheath tumor.